<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-30" modified="2017-10-25" version="142">
<accession>Q96EQ8</accession>
<accession>Q9NX39</accession>
<name>RN125_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="17">E3 ubiquitin-protein ligase RNF125</fullName>
<ecNumber evidence="5 6 7 10 11 13 14">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="18">RING finger protein 125</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="15">T-cell RING activation protein 1</fullName>
<shortName evidence="15">TRAC-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="18">RNF125</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="J. Biol." volume="2" first="21.1" last="21.16">
<title>Systematic identification of regulatory proteins critical for T-cell activation.</title>
<authorList>
<person name="Chu P."/>
<person name="Pardo J."/>
<person name="Zhao H."/>
<person name="Li C.C."/>
<person name="Pali E."/>
<person name="Shen M.M."/>
<person name="Qu K."/>
<person name="Yu S.X."/>
<person name="Huang B.C.B."/>
<person name="Yu P."/>
<person name="Masuda E.S."/>
<person name="Molineaux S.M."/>
<person name="Kolbinger F."/>
<person name="Aversa G."/>
<person name="de Vries J."/>
<person name="Payan D.G."/>
<person name="Liao X.C."/>
</authorList>
<dbReference type="PubMed" id="12974981"/>
<dbReference type="DOI" id="10.1186/1475-4924-2-21"/>
</citation>
<scope>IDENTIFICATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="J. Immunol." volume="174" first="5288" last="5297">
<title>A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.</title>
<authorList>
<person name="Zhao H."/>
<person name="Li C.C."/>
<person name="Pardo J."/>
<person name="Chu P.C."/>
<person name="Liao C.X."/>
<person name="Huang J."/>
<person name="Dong J.G."/>
<person name="Zhou X."/>
<person name="Huang Q."/>
<person name="Huang B.C.B."/>
<person name="Bennett M.K."/>
<person name="Molineaux S.M."/>
<person name="Lu H."/>
<person name="Daniel-Issakani S."/>
<person name="Payan D.G."/>
<person name="Masuda E.S."/>
</authorList>
<dbReference type="PubMed" id="15843525"/>
<dbReference type="DOI" id="10.4049/jimmunol.174.9.5288"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF GLY-2; CYS-37; CYS-40; HIS-54; CYS-57; CYS-72 AND CYS-75</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7500" last="7505">
<title>Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.</title>
<authorList>
<person name="Arimoto K."/>
<person name="Takahashi H."/>
<person name="Hishiki T."/>
<person name="Konishi H."/>
<person name="Fujita T."/>
<person name="Shimotohno K."/>
</authorList>
<dbReference type="PubMed" id="17460044"/>
<dbReference type="DOI" id="10.1073/pnas.0611551104"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF CYS-72 AND CYS-75</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="Virology" volume="368" first="191" last="204">
<title>The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells.</title>
<authorList>
<person name="Shoji-Kawata S."/>
<person name="Zhong Q."/>
<person name="Kameoka M."/>
<person name="Iwabu Y."/>
<person name="Sapsutthipas S."/>
<person name="Luftig R.B."/>
<person name="Ikuta K."/>
</authorList>
<dbReference type="PubMed" id="17643463"/>
<dbReference type="DOI" id="10.1016/j.virol.2007.06.028"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-37 AND CYS-40</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Biochem. J." volume="410" first="101" last="111">
<title>T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain.</title>
<authorList>
<person name="Giannini A.L."/>
<person name="Gao Y."/>
<person name="Bijlmakers M.J."/>
</authorList>
<dbReference type="PubMed" id="17990982"/>
<dbReference type="DOI" id="10.1042/BJ20070995"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>MUTAGENESIS OF GLY-2; CYS-37; CYS-40; VAL-217 AND SER-221</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="Hum. Mutat." volume="35" first="1436" last="1441">
<title>A new overgrowth syndrome is due to mutations in RNF125.</title>
<authorList>
<consortium name="SOGRI Consortium"/>
<person name="Tenorio J."/>
<person name="Mansilla A."/>
<person name="Valencia M."/>
<person name="Martinez-Glez V."/>
<person name="Romanelli V."/>
<person name="Arias P."/>
<person name="Castrejon N."/>
<person name="Poletta F."/>
<person name="Guillen-Navarro E."/>
<person name="Gordo G."/>
<person name="Mansilla E."/>
<person name="Garcia-Santiago F."/>
<person name="Gonzalez-Casado I."/>
<person name="Vallespin E."/>
<person name="Palomares M."/>
<person name="Mori M.A."/>
<person name="Santos-Simarro F."/>
<person name="Garcia-Minaur S."/>
<person name="Fernandez L."/>
<person name="Mena R."/>
<person name="Benito-Sanz S."/>
<person name="del Pozo A."/>
<person name="Silla J.C."/>
<person name="Ibanez K."/>
<person name="Lopez-Granados E."/>
<person name="Martin-Trujillo A."/>
<person name="Montaner D."/>
<person name="Heath K.E."/>
<person name="Campos-Barros A."/>
<person name="Dopazo J."/>
<person name="Nevado J."/>
<person name="Monk D."/>
<person name="Ruiz-Perez V.L."/>
<person name="Lapunzina P."/>
</authorList>
<dbReference type="PubMed" id="25196541"/>
<dbReference type="DOI" id="10.1002/humu.22689"/>
</citation>
<scope>INVOLVEMENT IN TNORS</scope>
<scope>VARIANTS TNORS ILE-112; LEU-163 AND CYS-174</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2015" name="Cell. Physiol. Biochem." volume="35" first="237" last="245">
<title>RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.</title>
<authorList>
<person name="Yang L."/>
<person name="Zhou B."/>
<person name="Li X."/>
<person name="Lu Z."/>
<person name="Li W."/>
<person name="Huo X."/>
<person name="Miao Z."/>
</authorList>
<dbReference type="PubMed" id="25591766"/>
<dbReference type="DOI" id="10.1159/000369691"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF CYS-72 AND CYS-75</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2015" name="Cell Rep." volume="11" first="1458" last="1473">
<title>Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation.</title>
<authorList>
<person name="Kim H."/>
<person name="Frederick D.T."/>
<person name="Levesque M.P."/>
<person name="Cooper Z.A."/>
<person name="Feng Y."/>
<person name="Krepler C."/>
<person name="Brill L."/>
<person name="Samuels Y."/>
<person name="Hayward N.K."/>
<person name="Perlina A."/>
<person name="Piris A."/>
<person name="Zhang T."/>
<person name="Halaban R."/>
<person name="Herlyn M.M."/>
<person name="Brown K.M."/>
<person name="Wargo J.A."/>
<person name="Dummer R."/>
<person name="Flaherty K.T."/>
<person name="Ronai Z.A."/>
</authorList>
<dbReference type="PubMed" id="26027934"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.04.049"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2015" name="EMBO J." volume="34" first="2903" last="2920">
<title>A non-canonical role of the p97 complex in RIG-I antiviral signaling.</title>
<authorList>
<person name="Hao Q."/>
<person name="Jiao S."/>
<person name="Shi Z."/>
<person name="Li C."/>
<person name="Meng X."/>
<person name="Zhang Z."/>
<person name="Wang Y."/>
<person name="Song X."/>
<person name="Wang W."/>
<person name="Zhang R."/>
<person name="Zhao Y."/>
<person name="Wong C.C."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="26471729"/>
<dbReference type="DOI" id="10.15252/embj.201591888"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH VCP</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="J. Immunol." volume="195" first="2251" last="2262">
<title>MicroRNA-15b Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF125.</title>
<authorList>
<person name="Zhu B."/>
<person name="Ye J."/>
<person name="Nie Y."/>
<person name="Ashraf U."/>
<person name="Zohaib A."/>
<person name="Duan X."/>
<person name="Fu Z.F."/>
<person name="Song Y."/>
<person name="Chen H."/>
<person name="Cao S."/>
</authorList>
<dbReference type="PubMed" id="26202983"/>
<dbReference type="DOI" id="10.4049/jimmunol.1500370"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="29232" last="29232">
<title>A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125.</title>
<authorList>
<person name="Bijlmakers M.J."/>
<person name="Teixeira J.M."/>
<person name="Boer R."/>
<person name="Mayzel M."/>
<person name="Puig-Sarries P."/>
<person name="Karlsson G."/>
<person name="Coll M."/>
<person name="Pons M."/>
<person name="Crosas B."/>
</authorList>
<dbReference type="PubMed" id="27411375"/>
<dbReference type="DOI" id="10.1038/srep29232"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) IN COMPLEX WITH ZINC</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH UBE2D1</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF 100-CYS--CYS-103 AND 109-LEU--ARG-113</scope>
</reference>
<comment type="function">
<text evidence="5 6 7 10 11 13 14">E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins, such as DDX58/RIG-I, MAVS/IPS1, IFIH1/MDA5, JAK1 and p53/TP53 (PubMed:15843525, PubMed:17460044, PubMed:17643463, PubMed:26027934, PubMed:26471729, PubMed:25591766, PubMed:27411375). Acts as a negative regulator of type I interferon production by mediating ubiquitination of DDX58/RIG-I at 'Lys-181', leading to DDX58/RIG-I degradation (PubMed:17460044, PubMed:26471729). Mediates ubiquitination and subsequent degradation of p53/TP53 (PubMed:25591766). Mediates ubiquitination and subsequent degradation of JAK1 (PubMed:26027934). Acts as a positive regulator of T-cell activation (PubMed:15843525).</text>
</comment>
<comment type="catalytic activity">
<text evidence="5 6 7 10 11 13 14">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway" evidence="5 6 7 10 11 13 14">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="13 14">Interacts with UBE2D1 (PubMed:27411375). Interacts with VCP/p97; leading to recruit RNF125 to DDX58/RIG-I and promote ubiquitination of DDX58/RIG-I (PubMed:26471729).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2339208"/>
<interactant intactId="EBI-15577823">
<id>O95786-1</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2339208"/>
<interactant intactId="EBI-6115771">
<id>Q9BYX4</id>
<label>IFIH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2339208"/>
<interactant intactId="EBI-15577799">
<id>Q7Z434-1</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2339208"/>
<interactant intactId="EBI-2129763">
<id>Q96LR5</id>
<label>UBE2E2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Golgi apparatus membrane</location>
<topology evidence="8">Lipid-anchor</topology>
</subcellularLocation>
<text evidence="8">Shows a reticular staining pattern within the cell and is probably expressed at other intracellular membranes in addition to the Golgi membrane. Not detected at the plasma membrane.</text>
</comment>
<comment type="tissue specificity">
<text evidence="4 5">Predominantly expressed in lymphoid tissues, including bone marrow, spleen and thymus. Also weakly expressed in other tissues. Predominant in the CD4(+) and CD8(+) T-cells, suggesting that it is preferentially confined to T-cells.</text>
</comment>
<comment type="induction">
<text evidence="11 12">Down-regulated by miR-15b (PubMed:26202983). Down-regulated in BRAFi resistant melanomas, leading to increased levels of JAK1 and possibly promoting BRAFi resistance.</text>
</comment>
<comment type="domain">
<text evidence="14">The C2HC RNF-type zinc finger and the linker region stabilize the RING-type zinc finger, leading to promote binding of the RING-type zinc finger to the ubiquitin-conjugating enzyme E2 (donor ubiquitin) (PubMed:27411375).</text>
</comment>
<comment type="PTM">
<text evidence="8">Autoubiquitinated, leading to its subsequent proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="9">
<disease id="DI-04352">
<name>Tenorio syndrome</name>
<acronym>TNORS</acronym>
<description>A disease characterized by overgrowth, macrocephaly, and intellectual disability. Some patients may have mild hydrocephaly, hypoglycemia, and inflammatory diseases resembling Sjogren syndrome.</description>
<dbReference type="MIM" id="616260"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="5 6 7 10 11 13 14"/>
<dbReference type="EMBL" id="AK000463">
<property type="protein sequence ID" value="BAA91182.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012021">
<property type="protein sequence ID" value="AAH12021.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11902.1"/>
<dbReference type="RefSeq" id="NP_060301.2">
<property type="nucleotide sequence ID" value="NM_017831.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.633703"/>
<dbReference type="PDB" id="5DKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B=1-232"/>
</dbReference>
<dbReference type="PDBsum" id="5DKA"/>
<dbReference type="ProteinModelPortal" id="Q96EQ8"/>
<dbReference type="SMR" id="Q96EQ8"/>
<dbReference type="BioGrid" id="120281">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="DIP" id="DIP-52778N"/>
<dbReference type="ELM" id="Q96EQ8"/>
<dbReference type="IntAct" id="Q96EQ8">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000217740"/>
<dbReference type="iPTMnet" id="Q96EQ8"/>
<dbReference type="PhosphoSitePlus" id="Q96EQ8"/>
<dbReference type="BioMuta" id="RNF125"/>
<dbReference type="DMDM" id="143811449"/>
<dbReference type="PaxDb" id="Q96EQ8"/>
<dbReference type="PeptideAtlas" id="Q96EQ8"/>
<dbReference type="PRIDE" id="Q96EQ8"/>
<dbReference type="Ensembl" id="ENST00000217740">
<property type="protein sequence ID" value="ENSP00000217740"/>
<property type="gene ID" value="ENSG00000101695"/>
</dbReference>
<dbReference type="GeneID" id="54941"/>
<dbReference type="KEGG" id="hsa:54941"/>
<dbReference type="UCSC" id="uc002kxf.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="54941"/>
<dbReference type="DisGeNET" id="54941"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000101695.8"/>
<dbReference type="GeneCards" id="RNF125"/>
<dbReference type="H-InvDB" id="HIX0014384"/>
<dbReference type="HGNC" id="HGNC:21150">
<property type="gene designation" value="RNF125"/>
</dbReference>
<dbReference type="HPA" id="HPA041514"/>
<dbReference type="MalaCards" id="RNF125"/>
<dbReference type="MIM" id="610432">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616260">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96EQ8"/>
<dbReference type="OpenTargets" id="ENSG00000101695"/>
<dbReference type="PharmGKB" id="PA134950383"/>
<dbReference type="eggNOG" id="ENOG410IJHI">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YBNH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063064"/>
<dbReference type="HOGENOM" id="HOG000230946"/>
<dbReference type="HOVERGEN" id="HBG098958"/>
<dbReference type="InParanoid" id="Q96EQ8"/>
<dbReference type="KO" id="K12170"/>
<dbReference type="OMA" id="YVNHSNT"/>
<dbReference type="OrthoDB" id="EOG091G0LBM"/>
<dbReference type="PhylomeDB" id="Q96EQ8"/>
<dbReference type="TreeFam" id="TF331012"/>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of DDX58/IFIH1 signaling"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="GeneWiki" id="RNF125"/>
<dbReference type="GenomeRNAi" id="54941"/>
<dbReference type="PRO" id="PR:Q96EQ8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 18"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000101695"/>
<dbReference type="CleanEx" id="HS_RNF125"/>
<dbReference type="ExpressionAtlas" id="Q96EQ8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96EQ8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034098">
<property type="term" value="C:VCP-NPL4-UFD1 AAA ATPase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0039536">
<property type="term" value="P:negative regulation of RIG-I signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008598">
<property type="entry name" value="Di19_Zn_binding_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR034734">
<property type="entry name" value="ZF_C2HC_RNF"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF05605">
<property type="entry name" value="zf-Di19"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51803">
<property type="entry name" value="ZF_C2HC_RNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="E3 ubiquitin-protein ligase RNF125" id="PRO_0000056090">
<location>
<begin position="2"/>
<end position="232"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="2">
<location>
<begin position="37"/>
<end position="76"/>
</location>
</feature>
<feature type="zinc finger region" description="C2HC RNF-type" evidence="3 16">
<location>
<begin position="100"/>
<end position="119"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the C2HC RNF-type zinc finger" evidence="14">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the RING-type zinc finger" evidence="14">
<location>
<begin position="109"/>
<end position="113"/>
</location>
</feature>
<feature type="region of interest" description="Linker region" evidence="14">
<location>
<begin position="120"/>
<end position="128"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with ubiquitin and for autoubiquitination" evidence="8">
<location>
<begin position="210"/>
<end position="224"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 14">
<location>
<position position="37"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 14">
<location>
<position position="40"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 14">
<location>
<position position="52"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 14">
<location>
<position position="54"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 14">
<location>
<position position="57"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 14">
<location>
<position position="60"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 14">
<location>
<position position="72"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 14">
<location>
<position position="75"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="1 14">
<location>
<position position="100"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="1 14">
<location>
<position position="103"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="1 14">
<location>
<position position="115"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="1 14">
<location>
<position position="119"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="N-myristoyl glycine" evidence="8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In TNORS; dbSNP:rs786201014." id="VAR_073353" evidence="9">
<original>M</original>
<variation>I</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In TNORS; dbSNP:rs373764886." id="VAR_073354" evidence="9">
<original>S</original>
<variation>L</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In TNORS; dbSNP:rs370242930." id="VAR_073355" evidence="9">
<original>R</original>
<variation>C</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation but not E3 ligase activity in vitro. Also abolishes myristoylation and membrane localization." evidence="5 7 8">
<original>G</original>
<variation>A</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-40." evidence="5 7 8">
<original>C</original>
<variation>A</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-37." evidence="5 8">
<original>C</original>
<variation>A</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-57." evidence="5">
<original>H</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-54." evidence="5">
<original>C</original>
<variation>A</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-75." evidence="5 6 10">
<original>C</original>
<variation>A</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to regulate T-cell activation and E3 ligase activity in vitro; when associated with A-72." evidence="5 6 10">
<original>C</original>
<variation>A</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished E3 ubiquitin-protein ligase activity in vitro." evidence="14">
<original>CAEC</original>
<variation>AAEA</variation>
<location>
<begin position="100"/>
<end position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished E3 ubiquitin-protein ligase activity in vitro." evidence="14">
<original>LSEMR</original>
<variation>ASEAA</variation>
<location>
<begin position="109"/>
<end position="113"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced ubiquitination and reduced binding to ubiquitinated proteins; when associated with Q-221." evidence="8">
<original>V</original>
<variation>P</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced ubiquitination and reduced binding to ubiquitinated proteins; when associated with P-217." evidence="8">
<original>S</original>
<variation>Q</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH12021." ref="2" evidence="17">
<original>TLVC</original>
<variation>IVLY</variation>
<location>
<begin position="105"/>
<end position="108"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA91182." ref="1" evidence="17">
<original>S</original>
<variation>N</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAH12021." ref="2" evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="45"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="55"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="67"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="87"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="112"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="120"/>
<end position="126"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DKA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01144"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12974981"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15843525"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17460044"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643463"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17990982"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25196541"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25591766"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26027934"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26202983"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26471729"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27411375"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12974981"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17990982"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<evidence key="18" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:21150"/>
</source>
</evidence>
<sequence length="232" mass="26454" checksum="E3D93D546AD99D81" modified="2007-04-03" version="4">
MGSVLSTDSGKSAPASATARALERRRDPELPVTSFDCAVCLEVLHQPVRTRCGHVFCRSC
IATSLKNNKWTCPYCRAYLPSEGVPATDVAKRMKSEYKNCAECDTLVCLSEMRAHIRTCQ
KYIDKYGPLQELEETAARCVCPFCQRELYEDSLLDHCITHHRSERRPVFCPLCRLIPDEN
PSSFSGSLIRHLQVSHTLFYDDFIDFNIIEEALIRRVLDRSLLEYVNHSNTT
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>